442 results on '"Morris, Stephan W."'
Search Results
2. Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes
3. Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy
4. An evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanol.
5. Data from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
6. Supplementary Figure 2 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
7. Supplementary Figure 1 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
8. Supplementary Figure 4 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
9. Supplementary Methods and Figure Legends from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
10. Supplementary Figure 3 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
11. CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells
12. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice
13. Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3
14. Bcl10 Plays a Critical Role in NF-κB Activation Induced by G Protein-Coupled Receptors
15. Bcl10 is an essential regulator for A20 gene expression
16. Abstract 1720: Ax-101, an immunostimulatory small molecule, markedly enhances the antitumor activity of PD1 immune checkpoint blockade in multiple preclinical solid tumor models
17. Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study
18. Eμ-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-κB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma
19. c-Myc–mediated control of cell fate in megakaryocyte-erythrocyte progenitors
20. Role for MKL1 in megakaryocytic maturation
21. Design and synthesis of a novel tyrosine kinase inhibitor template
22. Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin's Lymphoma
23. Activating mutations in ALK provide a therapeutic target in neuroblastoma
24. Bcl10 plays a critical role in NF-[kappa]B activation induced by G protein-coupled receptors
25. cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP
26. The oncogenic fusion protein nucleophosmin–anaplastic lymphoma kinase (NPM–ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model
27. Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14)
28. Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis
29. Translocations involving anaplastic lymphoma kinase (ALK)
30. Matrix Stiffness-Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction
31. Inhibition of caspase-8 activity caused by overexpression of bcl10 contributes to the pathogenesis of high-grade MALT lymphoma
32. Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase: Functions and genetic interactions in learning, memory and adult neurogenesis
33. Chromosomal location and tissue expression of the gene encoding the adenovirus E1A-regulated transcription factor E4F in humans and mice
34. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
35. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
36. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity
37. Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values
38. Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-hodgkinʼs lymphoma
39. Abstract 3067: OHM-581, a dual JAK2-BET inhibitor for the treatment of myelofibrosis and other hematologic malignancies
40. A β2-Integrin/MRTF-A/SRF Pathway Regulates Dendritic Cell Gene Expression, Adhesion, and Traction Force Generation
41. Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
42. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies
43. Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease
44. Nucleophosmin–anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
45. A New Recurrent Translocation, t(5;11)(q35;p15.5), Associated With del(5q) in Childhood Acute Myeloid Leukemia
46. Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma
47. Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
48. MLF1 is a proapoptotic antagonist of HOP complex-mediated survival
49. Covalent-103: A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study of Bmf-500, an Oral Covalent FLT3 Inhibitor, in Adults with Acute Leukemia (AL)
50. Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.